Sanofi and Zealand Shares Drop

Sanofi and Zealand Shares Drop

Sources confirm that the U. S. setback for the diabetes drug has severely hit Sanofi and Zealand.

According to the statements released by the French Drugmaker Sanofi on Thursday, it has decided to presently withdraw its U. S. application for the diabetes treatment lixisenatide. The company officials said that they await the results of the ongoing cardiovascular patient study.

The company's above decision will delay the launch of the drug in the world's biggest market. As an immediate effect of its decision, the position of its shares in the market has fallen down by 1.6 percent. At 0720 GMT, the shares of Sanofi reported down along with a trembling position of its smaller Danish partner Zealand Pharma too, which dropped by 20 percent.

Sanofi look forward at resubmitting its application in 2015. It said that till then the cardiovascular test will be complete. The company's decision is not at all concerned with the safety issues or deficiencies in the new drug application, the officials explained.

Europe government has already approved the selling of Lixisenatide under the brand name Lyxumia. But, Sanofi awaits the full results of the evaluation of lixisenatide in acute coronary syndrome. The new drug will treat the patients with high cardiovascular risk.


FrenchTribune Specials

Twitter to simplify 140-character rule in coming months

In a blog post published on Tuesday, popular microblogging service Twitter has officially announced that it will be rolling out changes to its 140-character tweet limit in the coming months. The move is being described by Twitter as an effort to ease up on the content which counts towards the 140-character limit.

In an official...

Most Popular

Report: China has increased its scrutiny of foreign-made consumer tech products

According to The New York Times, the scrutiny of foreign...

Google likely to focus on VR and AI at I/O conference this week

At Google's 2016 I/O developer conference scheduled to...

Twitter may stop counting photos and links towards its 140-character limit

According to a Bloomberg report published on Monday,...

Danish researchers face criticism for publishing OkCupid users’ data

A team of Danish researchers triggered a controversy...

Poll

Can Greece Come out of Economic Problems: